| Line Item | 2025-01-31 | Y/Y |
|---|---|---|
| Revenue | $244.4M | +10.7% |
| Cost of Revenue | $104.6M | -2.9% |
| Gross Profit | $139.7M | +23.7% |
| R&D Expense | $101.0M | -13.2% |
| SG&A Expense | $77.1M | -3.6% |
| Operating Income | -$116.1M | +31.6% |
| Pre-tax Income | -$120.7M | +13.6% |
| Income Tax | $2.5M | +201.8% |
| Net Income | -$123.2M |
| Line Item | 2025-01-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $118.0M | +40.8% |
| Accounts Receivable | $55.8M | +28.9% |
| Current Assets | $302.2M | -18.4% |
| Total Assets | $633.8M | -9.7% |
| Current Liabilities | $142.1M | +4.0% |
| Total Liabilities | $192.5M | +4.6% |
| Stockholders' Equity | $441.3M | -14.8% |
| Line Item | 2025-01-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$14.4M | +71.7% |
| Capital Expenditures | $44.3M | +16.6% |
| Investing Cash Flow | $57.9M | +272.4% |
| Financing Cash Flow | -$15.5M | -872.2% |
| Free Cash Flow | -$58.7M | +33.9% |
| +12.3% |
| EPS (Basic) | -$0.42 | +16.0% |
| EPS (Diluted) | -$0.42 | +16.0% |